Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 3
2022 5
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean granville m (38 results)?
Development of hybrid immunity during a period of high incidence of Omicron infections.
Frei A, Kaufmann M, Amati R, Butty Dettwiler A, von Wyl V, Annoni AM, Vincentini J, Pellaton C, Pantaleo G, Fehr JS, D'Acremont V, Bochud M, Albanese E, Puhan MA; Corona Immunitas Research Group. Frei A, et al. Int J Epidemiol. 2023 Dec 25;52(6):1696-1707. doi: 10.1093/ije/dyad098. Int J Epidemiol. 2023. PMID: 37407273 Free PMC article.
Persistent symptoms after SARS-CoV-2 infection in children: a cross-sectional population-based serological study.
Dumont R, Nehme M, Lorthe E, De Mestral C, Richard V, Baysson H, Pennacchio F, Lamour J, Semaani C, Zaballa ME, Pullen N, Perrin A, L'Huillier AG, Posfay-Barbe KM, Guessous I, Stringhini S; Specchio-COVID19 study group. Dumont R, et al. BMJ Open. 2022 Nov 21;12(11):e063504. doi: 10.1136/bmjopen-2022-063504. BMJ Open. 2022. PMID: 36410813 Free PMC article.
Occupational risk of SARS-CoV-2 infection and reinfection during the second pandemic surge: a cohort study.
Leidi A, Berner A, Dumont R, Dubos R, Koegler F, Piumatti G, Vuilleumier N, Kaiser L, Balavoine JF, Trono D, Pittet D, Chappuis F, Kherad O, Courvoisier DS, Azman AS, Zaballa ME, Guessous I, Stringhini S; SEROCoV-WORK+ study group. Leidi A, et al. Occup Environ Med. 2022 Feb;79(2):116-119. doi: 10.1136/oemed-2021-107924. Epub 2021 Dec 8. Occup Environ Med. 2022. PMID: 34880045
Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland.
Stringhini S, Zaballa ME, Pullen N, de Mestral C, Perez-Saez J, Dumont R, Picazio A, Pennacchio F, Dibner Y, Yerly S, Baysson H, Vuilleumier N, Balavoine JF, Bachmann D, Trono D, Pittet D, Chappuis F, Kherad O, Kaiser L, Azman AS; SEROCoV-WORK + Study Group; Guessous I. Stringhini S, et al. Nat Commun. 2021 Jun 8;12(1):3455. doi: 10.1038/s41467-021-23796-4. Nat Commun. 2021. PMID: 34103517 Free PMC article.
Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland.
Baysson H, Pennachio F, Wisniak A, Zabella ME, Pullen N, Collombet P, Lorthe E, Joost S, Balavoine JF, Bachmann D, Azman A, Pittet D, Chappuis F, Kherad O, Kaiser L, Guessous I, Stringhini S; Specchio-COVID19 study group. Baysson H, et al. BMJ Open. 2022 Jan 31;12(1):e055515. doi: 10.1136/bmjopen-2021-055515. BMJ Open. 2022. PMID: 35105645 Free PMC article.
Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study.
Leidi A, Koegler F, Dumont R, Dubos R, Zaballa ME, Piumatti G, Coen M, Berner A, Darbellay Farhoumand P, Vetter P, Vuilleumier N, Kaiser L, Courvoisier D, Azman AS, Guessous I, Stringhini S; SEROCoV-POP study group. Leidi A, et al. Clin Infect Dis. 2022 Mar 1;74(4):622-629. doi: 10.1093/cid/ciab495. Clin Infect Dis. 2022. PMID: 34043763 Free PMC article.
Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study.
Tancredi S, Chiolero A, Wagner C, Haller ML, Chocano-Bedoya P, Ortega N, Rodondi N, Kaufmann L, Lorthe E, Baysson H, Stringhini S, Michel G, Lüdi C, Harju E, Frank I, Imboden M, Witzig M, Keidel D, Probst-Hensch N, Amati R, Albanese E, Corna L, Crivelli L, Vincentini J, Gonseth Nusslé S, Bochud M, D'Acremont V, Kohler P, Kahlert CR, Cusini A, Frei A, Puhan MA, Geigges M, Kaufmann M, Fehr J, Cullati S; Corona Immunitas Research Group. Tancredi S, et al. Infection. 2023 Oct;51(5):1453-1465. doi: 10.1007/s15010-023-02011-0. Epub 2023 Mar 4. Infection. 2023. PMID: 36870034 Free PMC article.
Changes in socioeconomic resources and mental health after the second COVID-19 wave (2020-2021): a longitudinal study in Switzerland.
Tancredi S, Ulytė A, Wagner C, Keidel D, Witzig M, Imboden M, Probst-Hensch N, Amati R, Albanese E, Levati S, Crivelli L, Kohler P, Cusini A, Kahlert C, Harju E, Michel G, Lüdi C, Ortega N, Baggio S, Chocano-Bedoya P, Rodondi N, Ballouz T, Frei A, Kaufmann M, Von Wyl V, Lorthe E, Baysson H, Stringhini S, Schneider V, Kaufmann L, Wieber F, Volken T, Zysset A, Dratva J, Cullati S; Corona Immunitas Research Group. Tancredi S, et al. Int J Equity Health. 2023 Mar 23;22(1):51. doi: 10.1186/s12939-023-01853-2. Int J Equity Health. 2023. PMID: 36959642 Free PMC article.
Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland.
West EA, Anker D, Amati R, Richard A, Wisniak A, Butty A, Albanese E, Bochud M, Chiolero A, Crivelli L, Cullati S, d'Acremont V, Epure AM, Fehr J, Flahault A, Fornerod L, Frank I, Frei A, Michel G, Gonseth S, Guessous I, Imboden M, Kahlert CR, Kaufmann L, Kohler P, Mösli N, Paris D, Probst-Hensch N, Rodondi N, Stringhini S, Vermes T, Vollrath F, Puhan MA; Corona Immunitas Research Group. West EA, et al. Int J Public Health. 2020 Dec;65(9):1529-1548. doi: 10.1007/s00038-020-01494-0. Epub 2020 Oct 24. Int J Public Health. 2020. PMID: 33098441 Free PMC article.
11 results